Du är nu på väg att lämna en GSK-hemsida

Denna länk leder till en hemsida som inte tillhör GSK. GSK tar inget ansvar för innehållet på tredje parts hemsidor.

Fortsätt

Tillbaka

  • ASYEVE0001=Event Registration-Portal
  • ASYEVE0002=Watched General Video
  • ASYEVE0003=Watched Virtual Rep Video
  • ASYEVE0004=Watched Patient Video
  • ASYEVE0005=Watched Expert Video
  • ASYEVE0006=Watched Webcast
  • ASYEVE0007=Downloaded Content-Portal
  • ASYEVE0008=Clicked to App Store
  • ASYEVE0009=Watched Learning Module Video
  • ASYEVE0010=eMail Sent
  • ASYEVE0011=eMail Read
  • ASYEVE0012=eMail Clicked
  • ASYEVE0013=Shared a Link
  • ASYEVE0014=Rep Request
  • ASYEVE0015=Joined health.gsk
  • ASYEVE0016=email Not Sent
  • ASYEVE0017=Email Not Sent
  • ASYEVE0018=Email Not Sent
  • ASYEVE0037=IJSFAID is not available
  • ASYEVE0038=EMAIL ID and IJSFAID is not available
  • ASYEVE0039=The user is opted out
  • ASYEVE0040=Scope IDs are different

Contact request

Stay informed

Antiviral treatment of HIV infection

Since 2002, the Reference Group for Antiviral Therapy (RAV) and the Medical Products Agency have regularly published national recommendations for antiretroviral treatment of HIV infection. In the autumn of 2021, a working group led by RAV revised the recommendations again. Listen to Prof. Magnus Gisslén talking about the significant news in the 2021 treatment guidelines.

Magnus Gisslén is professor of Infectious Diseases at the University of Gothenburg, Sweden.

Video player requires JavaScript enabled. You can download this video here: https://videos.gskstatic.com/pharma/Health/Sweden/se-gisslen-antiviral-behandling-av-hivinfektion.mp4